Journal
JOURNAL OF IMMUNOLOGY
Volume 169, Issue 2, Pages 702-713Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.169.2.702
Keywords
-
Categories
Funding
- NHLBI NIH HHS [HL69722] Funding Source: Medline
- NIDDK NIH HHS [DK375105, DK52898, DK59793] Funding Source: Medline
Ask authors/readers for more resources
Recent evidence indicates that phagocytic clearance of apoptotic cells, initially thought to be a silent event, can modulate macrophage (Mphi) function. We show in this; work that phagocytic uptake of apoptotic cells or bodies, in the absence of serum or soluble survival factors, inhibits apoptosis; and maintains viability of primary cultures of murine peritoneal and bone marrow Mphi with a potency approaching that of serum-supplemented medium. Apoptotic uptake also profoundly inhibits the proliferation of bone marrow Mphi stimulated to proliferate by M-CSF. While inhibition of proliferation is an unusual property for survival factors, the combination of increased survival and decreased proliferation may aid the Mphi in its role as a scavenger during resolution of inflammation. The ability of apoptotic cells to promote survival and inhibit proliferation appears to be the result of simultaneous activation of Akt and inhibition of the mitogen-activated protein kinases extracellular signal-regulated kinase (ERK)1 and ERK2 (ERK1/2). While several activators of the innate immune system, or danger signals, also inhibit apoptosis and proliferation, danger signals and necrotic cells differ from apoptotic cells in that they activate, rather than inhibit, ERK1/2. These signaling differences may underlie the opposing tendencies of apoptotic cells and danger signals in promoting tolerance vs immunity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available